Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...

Erasca reported favorable safety and tolerability with no dose-limiting toxicities and predominantly low-grade adverse events across all dose levels. Initial Phase 1 monotherapy data for ERAS-0015 are ...

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center , positioning the company for ...

Detailed price information for Radiopharm Theranostics Limited ADR (RADX-Q) from The Globe and Mail including charting and trades.

Austin FC owners Simone, Tench Coxe are providing seed money to encourage others to donate to $2.5 billion project for a ...

Radiopharm Ventures, LLC, is a joint venture created in 2022 between MD Anderson Cancer Center and Radiopharm TheranosticsLeading candidate Betabart, a monoclonal antibody targeting B7H3, has received ...

Radiopharm Ventures, LLC, is a joint venture created in 2022 between MD Anderson Cancer Center and Radiopharm Theranostics Leading candidate ...

Oncolytics Biotech Inc. (NASDAQ:ONCY) is included in our list of the stocks under $1 that will explode. Oncolytics Biotech ...

As of Friday, January 09, Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 5.01%, which has investors questioning ...

As of Friday, January 09, Allogene Therapeutics, Inc.’s ALLO share price has surged by 18.13%, which has investors ...